Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dürr, Oliver | - |
dc.contributor.author | Franzini, Anca | - |
dc.contributor.author | Brutsche, Martin | - |
dc.contributor.author | Baty, Florent | - |
dc.date.accessioned | 2018-12-17T08:19:05Z | - |
dc.date.available | 2018-12-17T08:19:05Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0904-1850 | de_CH |
dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/13893 | - |
dc.description | Abstract | de_CH |
dc.language.iso | en | de_CH |
dc.publisher | European Respiratory Society | de_CH |
dc.relation.ispartof | The European Respiratory Journal | de_CH |
dc.rights | Licence according to publishing contract | de_CH |
dc.subject.ddc | 572: Biochemie | de_CH |
dc.subject.ddc | 616: Innere Medizin und Krankheiten | de_CH |
dc.title | Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) | de_CH |
dc.type | Konferenz: Sonstiges | de_CH |
dcterms.type | Text | de_CH |
zhaw.departement | School of Engineering | de_CH |
zhaw.organisationalunit | Institut für Datenanalyse und Prozessdesign (IDP) | de_CH |
zhaw.conference.details | 22nd Annual Congress of the European Respiratory Society, Munich, Germany, 6-10 September 2014 | de_CH |
zhaw.funding.eu | No | de_CH |
zhaw.issue | Suppl 58 | de_CH |
zhaw.originated.zhaw | Yes | de_CH |
zhaw.publication.status | publishedVersion | de_CH |
zhaw.volume | 44 | de_CH |
zhaw.publication.review | Peer review (Abstract) | de_CH |
Appears in collections: | Publikationen School of Engineering |
Files in This Item:
There are no files associated with this item.
Show simple item record
Dürr, O., Franzini, A., Brutsche, M., & Baty, F. (2014). Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) [Conference presentation]. The European Respiratory Journal, 44(Suppl 58).
Dürr, O. et al. (2014) ‘Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)’, in The European Respiratory Journal. European Respiratory Society.
O. Dürr, A. Franzini, M. Brutsche, and F. Baty, “Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC),” in The European Respiratory Journal, 2014, vol. 44, no. Suppl 58.
DÜRR, Oliver, Anca FRANZINI, Martin BRUTSCHE und Florent BATY, 2014. Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC). In: The European Respiratory Journal. Conference presentation. European Respiratory Society. 2014
Dürr, Oliver, Anca Franzini, Martin Brutsche, and Florent Baty. 2014. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” Conference presentation. In The European Respiratory Journal. Vol. 44. European Respiratory Society.
Dürr, Oliver, et al. “Tumor-Associated Stromal Gene Expression Signatures Predict Therapeutic Response to Erlotinib/Bevacizumab in Non-Small Cell Lung Cancer (NSCLC).” The European Respiratory Journal, vol. 44, no. Suppl 58, European Respiratory Society, 2014.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.